contempl
recent
career
path
review
broad
rang
scientif
question
promin
studi
area
scienc
signific
impact
fact
studi
anyth
highli
impact
area
question
demand
definit
constitut
high
impact
decid
creat
definit
impact
threat
life
relat
threat
human
life
highest
impact
like
thing
threaten
human
life
may
also
threaten
life
present
greatest
threat
human
life
today
histori
provid
critic
insight
answer
question
comprehens
look
would
seek
caus
mass
extinct
past
billion
year
life
earth
perspect
trend
subject
scienc
focu
five
mass
extinct
inher
bias
focus
mass
extinct
event
fail
appreci
small
live
thing
singl
cell
organ
bacteria
anoth
bia
order
appreci
life
past
life
form
must
occasion
produc
fossil
die
concern
asid
geolog
event
threaten
surviv
live
thing
tabl
actual
event
caus
extinct
frequent
debat
exampl
asteroid
impact
million
year
ago
coast
mexico
accompani
massiv
tsunami
respons
mass
extinct
montana
impact
may
also
trigger
enorm
volcano
india
result
ash
lava
flow
respons
region
speci
extinct
collect
dust
result
prolong
climat
chang
probabl
respons
even
speci
extinct
lesson
remain
volcan
erupt
climat
chang
asteroid
impact
threaten
life
highli
signific
way
respons
extens
select
pressur
unfortun
event
unpredict
enorm
littl
done
mass
extinct
may
repres
legitim
threat
select
pressur
larg
number
speci
complet
erad
leav
survivor
drive
evolut
final
outsid
remov
dinosaur
mammal
could
thrive
impact
event
human
life
human
yet
earth
event
took
place
refin
search
dramat
chang
human
popul
move
period
last
year
mass
migrat
took
place
everi
year
line
precess
earth
lead
possibl
linkag
earth
precess
human
migrat
may
due
region
climat
chang
like
ice
age
northern
hemispher
howev
human
popul
chang
timescal
easili
document
estim
climat
human
popul
dynam
limit
time
refin
search
consid
exponenti
growth
outbreak
tent
caterpillar
montana
report
david
quammen
book
spillov
quammen
extens
caterpillar
popul
consum
leav
local
elm
cottonwood
tree
summer
caterpillar
activ
produc
crackl
sound
like
distant
brushfir
citi
attack
insect
broad
arsen
modern
countermeasur
effect
howev
nuclear
polyhedrosi
viru
npv
use
caterpillar
host
densiti
like
critic
mass
nuclear
weapon
explod
destroy
caterpillar
epic
battl
caterpillar
popul
retreat
undetect
level
singl
season
result
npv
human
popul
chang
past
year
particular
emphasi
recent
year
human
popul
curv
segment
time
show
exponenti
growth
period
interrupt
middl
age
plagu
hypothesi
plagu
pandem
infecti
diseas
event
appear
greatest
threat
human
life
infecti
diseas
kill
million
peopl
year
percent
total
million
annual
death
global
popul
fauci
moren
brief
review
pandem
infect
past
year
illumin
sever
event
reduc
human
popul
plagu
athen
bce
kill
percent
human
popul
tabl
bacteri
viral
pandem
infect
signific
human
killer
bacteria
like
yersina
pesti
kill
half
popul
europ
smallpox
viru
kill
human
popul
mexico
pandem
infect
restrict
histori
long
time
spanish
flu
pandem
kill
million
peopl
grandpar
would
tell
stori
watch
hors
drawn
hears
daili
carri
dead
indiana
small
villag
safe
conclud
pandem
infect
current
relev
repres
one
signific
threat
human
surviv
yersinia
pesti
bacterium
caus
plagu
flea
infect
pesti
transmit
bacterium
rodent
primari
host
chang
environ
may
lead
movement
rat
popul
area
human
becom
infect
homer
point
infect
iliad
descript
trojan
war
bce
plagu
return
sever
time
sinc
trojan
war
impos
enorm
loss
human
life
tabl
recent
plagu
epidem
kill
ten
million
peopl
india
earli
centuri
pesti
still
readi
favor
condit
pounc
human
popul
outcom
like
less
dramat
due
understand
sanit
practic
quarantin
avail
antibiot
infect
greatest
threat
human
life
critic
driver
evolut
clearli
infect
pose
select
pressur
human
popul
origin
evolutionari
thought
includ
infect
darwin
establish
key
evolut
concept
galapago
island
island
isol
unlik
place
spread
infect
concept
speciat
point
geograph
separ
popul
infect
would
like
restrict
isol
popul
mani
case
surviv
select
pressur
identifi
ascrib
insuffici
sourc
food
unfortun
common
singlestrand
rna
virus
unstabl
limit
data
viral
fossil
record
pandem
infect
remain
threat
human
surviv
presenc
inform
revolut
daili
medic
breakthrough
global
travel
human
retroviru
hiv
current
global
infect
infect
popul
southern
eastern
africa
project
death
toll
million
measl
kill
million
peopl
last
year
develop
effect
vaccin
reduc
concern
infect
death
year
vaccin
program
frequent
disrupt
due
complac
result
vaccin
success
conflict
shift
healthcar
focu
social
crisi
recent
ebola
outbreak
west
africa
smallpox
also
ancient
infect
caus
fever
skin
lesion
time
death
king
rams
v
egypt
thought
die
smallpox
around
bce
introduc
mexico
smallpox
kill
million
aztec
indian
half
popul
period
year
proceed
decim
popul
south
america
variola
highli
infecti
viru
kill
million
peopl
centuri
inspir
erad
campaign
variola
erad
decemb
de
cock
rare
triumph
public
health
deserv
acknowledg
unpreced
accomplish
proof
concept
human
suffer
inevit
howev
variola
dna
viru
limit
rate
mutat
narrow
host
rang
anim
reservoir
exist
erad
viral
infect
challeng
world
continu
confront
broad
array
microbi
threat
progress
prepared
make
engag
like
success
microb
resurfac
infect
experi
medic
epidemiolog
uncertainti
surround
emerg
infecti
diseas
challeng
us
novelti
pandem
domin
infecti
diseas
fear
factor
pandem
began
much
frequent
occurr
epidem
epidem
come
emerg
infecti
agent
signific
problem
face
life
earth
today
concept
emerg
human
centric
term
infect
endem
anim
host
serv
viral
reservoir
report
univers
edinburgh
identifi
human
pathogen
emerg
reemerg
zoonot
jump
anim
host
human
numer
emerg
infect
caus
viral
agent
impos
high
impact
human
surviv
tabl
viral
agent
tabl
genom
base
singlestrand
rna
except
hbv
focu
scientif
attent
rna
numer
question
strike
investig
ponder
collect
viral
agent
like
tabl
viral
polymeras
error
replic
singlestrand
rna
genom
correct
speci
constantli
chang
appar
success
virus
move
reservoir
host
human
human
becom
immun
initi
infect
popul
divers
genom
offer
multipl
chanc
adapt
find
fit
genom
version
propag
next
transit
requir
adapt
acquir
immunodefici
syndrom
aid
caus
human
immunodefici
viru
retroviru
virus
singlestrand
rna
genom
convert
dna
paradigm
shift
flow
genet
inform
dna
rna
human
death
caus
tabl
accompani
spectrum
clinic
sign
eg
fever
diarrhea
peripher
neuropathi
pelvic
inflammatori
diseas
cervic
cancer
cytomegaloviru
retin
kaposi
sarcoma
lymphoma
infect
recurr
pneumonia
wast
syndrom
genom
divers
includ
base
substitut
insert
delet
recombin
gain
loss
glycosyl
site
aris
limit
fidel
viral
revers
transcriptas
mutat
found
cluster
hypervari
region
indic
fit
viru
select
vast
number
lessfit
genom
sequenc
emphas
key
observ
eid
signific
contemporari
concern
prepar
novel
characterist
introduc
eid
clinic
sign
divers
often
mimic
symptom
diseas
replic
mechan
often
error
prone
result
array
fit
virus
dengu
flaviviru
posit
sens
singlestrand
rna
ssrna
genom
carri
mosquito
man
dengu
tropic
diseas
hundr
year
typic
diseas
young
children
emerg
sever
recogn
manila
tabl
hemorrhag
fever
dhf
dengu
shock
syndrom
dss
billion
peopl
risk
dengu
infect
small
fraction
infect
develop
dhf
dh
infect
peopl
develop
antibodi
lead
antibodydepend
enhanc
ade
subsequ
infect
sever
dhf
dss
outcom
appear
ade
event
occur
peopl
produc
immunoglobin
igg
enhanc
affin
activ
fc
receptor
due
subclass
lack
fucos
glycan
modif
igg
wang
et
al
primari
vector
transmit
dengu
new
vector
carri
dengu
southern
unit
state
emerg
dengu
southern
unit
state
like
due
use
tire
import
japan
provid
place
asian
tiger
mosquito
live
outbreak
dengu
fever
becom
numer
sever
past
three
decad
viral
fit
constrain
requir
impos
natur
host
low
probabl
event
viru
move
natur
host
human
insect
frequent
play
role
vector
carri
viru
anim
reservoir
human
sever
zoonot
virus
transmit
place
human
near
rodent
sever
arenavirus
minu
sens
singlestrand
rna
virus
jump
rodent
natur
host
directli
human
contact
rodent
urin
saliva
notabl
arenavirus
name
hemorrhag
fever
hf
region
zoonosi
bolivian
hf
caus
machupo
macv
argentin
hf
caus
junin
junv
venezuelan
hf
caus
guanarito
gotv
south
american
outbreak
caus
new
world
arenavirus
contrast
lassa
hf
lasv
african
old
world
arenaviru
lasv
endem
diseas
west
africa
tabl
confus
dhf
ebola
infect
virus
transmit
arthropod
vector
call
arbovirus
yellow
fever
six
known
arbovirus
caus
diseas
human
discoveri
arboviru
caus
human
diseas
expand
begin
late
western
eastern
equin
encephalomyel
weev
eeev
st
loui
enceph
chickungunya
zika
tabl
arbovirus
emerg
becom
global
infect
twentyfirst
centuri
zika
becam
infam
caus
microcephali
newborn
infect
mother
guillainbarr
syndrom
sexual
transmit
human
work
therapeut
treatment
ebola
infect
genom
sequenc
recov
outbreak
differ
studi
conduct
usamriid
facil
expert
ebola
investig
rhesu
monkey
macaca
mulatta
inject
plaqu
form
unit
pfu
zair
ebolaviru
zebov
kikwit
thigh
muscl
untreat
control
monkey
die
day
follow
viral
inject
measur
viral
burden
quantit
polymeras
chain
reaction
qrt
pcr
measur
genom
copi
per
millilit
copiesml
plasma
plaqu
format
measur
infecti
virus
per
ml
pfuml
plasma
found
averag
genom
copi
per
ml
day
post
infect
pfuml
day
nearli
genom
present
success
viru
nonhuvwa
observ
domin
popul
viral
genom
sequenc
chang
one
individu
anoth
one
time
anoth
within
individu
exist
defect
viral
genom
may
offer
potenti
rapid
chang
stabl
host
chang
rapid
one
consid
magnitud
differ
condit
viru
jump
reservoir
host
human
rapid
adapt
great
advantag
viru
kill
host
success
viru
perhap
defect
viral
particl
facilit
host
immun
respons
give
chanc
catch
rapidli
prolifer
viru
ebola
outbreak
illumin
collater
damag
accompani
eid
outbreak
first
first
respond
local
physician
care
giver
kill
leav
popul
lack
doctor
nurs
even
physician
train
exercis
appropri
caution
interact
patient
dr
sheik
humarr
khan
die
ebola
infect
bausch
et
al
second
women
main
caregiv
famili
percent
ebola
death
outbreak
women
leav
famili
lack
tradit
structur
third
outbreak
disrupt
product
labor
market
trade
result
scarciti
inflat
food
price
food
secur
nutrit
diminish
preferenti
affect
poor
peopl
spend
incom
food
final
public
health
measur
discontinu
outbreak
percent
children
west
africa
receiv
routin
vaccin
figur
fell
percent
west
africa
loss
measl
vaccin
follow
measl
outbreak
unit
state
suggest
global
respons
region
loss
public
health
coronavirus
uniqu
larg
singlestrand
rna
genom
base
often
associ
mild
diseas
bronchiti
gastroenter
outbreak
sever
acut
respiratori
syndrom
coronaviru
sarscov
china
rapidli
spread
case
countri
tabl
retrospect
analysi
outbreak
link
zoonosi
culinari
trend
peopl
sought
exot
anim
eat
nontradit
food
anim
appear
street
market
urban
area
bring
peopl
close
reservoir
host
trigger
outbreak
civet
cat
identifi
sourc
first
human
case
natur
host
natur
host
fruit
bat
infect
varieti
small
mammal
includ
civet
cat
point
intervent
remov
civet
cat
market
natur
bat
host
remain
environ
maintain
viru
next
outbreak
second
coronaviru
outbreak
middl
east
respiratori
syndrom
coronaviru
mer
cov
rapidli
involv
countri
includ
africa
western
europ
southeast
asia
number
case
rel
low
case
fatal
ratio
great
concern
tabl
camel
reservoir
host
case
may
natur
host
sinc
camel
often
get
sick
well
transit
animaltohuman
transmiss
effici
humantohuman
transmiss
observ
quickli
case
sarscov
merscov
rapid
adapt
highli
infecti
viru
group
rais
concern
endem
coronavirus
companion
anim
sinc
virus
clearli
becom
pathogen
jump
anim
human
becom
transmit
humantohuman
ongo
outbreak
yellow
fever
africa
tabl
strike
remind
eid
reemerg
virtual
popul
peopl
recov
acut
symptom
liver
damag
caus
yellow
skin
reason
name
diseas
liver
damag
lead
bleed
kidney
damag
occasion
death
yellow
fever
flaviviru
origin
africa
distribut
world
barg
sail
ship
tropic
port
viru
arriv
america
slave
ship
viru
interrupt
build
panama
canal
attract
attent
walter
reed
militari
physician
respons
demonstr
transmiss
mosquito
effect
vaccin
use
worldwid
immun
last
year
limit
vaccin
like
popul
need
vaccin
regularli
world
constantli
chang
due
polit
econom
driver
lead
vaccin
gap
deni
burkitt
identifi
unusu
tumor
uganda
mulago
hospit
boy
swell
jaw
burkitt
lymphoma
saw
second
case
jinja
district
hospit
shore
lake
victoria
becam
curios
review
hospit
case
note
confirm
preval
tumor
jaw
accompani
swell
kidney
ovari
adren
gland
liver
assembl
data
patient
histolog
examin
led
descript
lymphoma
syndrom
african
lymphoma
burkitt
receiv
grant
visit
hospit
eight
african
countri
uganda
kenya
tanzania
malawi
mozambiqu
zimbabw
zambia
republ
south
africa
investig
african
lymphoma
tumor
found
everywher
equat
area
yearround
temperatur
area
feet
elev
burkitt
determin
tumor
occur
annual
rainfal
inch
seen
dri
savannah
nigeria
burkitt
contact
doctor
papua
new
guinea
discov
tumor
common
childhood
tumor
countri
wet
coastal
region
dri
highland
area
burkitt
work
hypothesi
insect
transmit
viru
infect
respons
lymphoma
syndrom
observ
adult
lymphoma
individu
move
african
lymphoma
belt
tumor
observ
unit
state
europ
rate
per
million
less
frequent
africa
biopsi
sampl
produc
virus
none
came
insect
work
hypothesi
abandon
new
hypothesi
emerg
parasit
caus
malaria
caus
agent
lymphoma
believ
sever
malaria
play
role
develop
burkitt
lymphoma
advic
peter
clifford
burkitt
administ
methotrex
treat
patient
produc
encourag
result
burkitt
gave
lectur
middlesex
hospit
commonest
children
cancer
tropic
africa
hitherto
unrecogn
syndrom
anthoni
epstein
attend
lectur
chang
life
provid
punctuat
mark
histori
scienc
epstein
introduc
lectur
two
sat
tea
burkitt
agre
send
tumor
specimen
epstein
epstein
receiv
grant
us
nation
institut
health
allow
employ
two
research
assist
yvonn
barr
one
research
assist
abl
propag
viru
tri
tumor
specimen
research
assist
bert
achong
electron
microscopist
first
identifi
viru
member
herp
viru
famili
viru
bear
name
epstein
barr
viru
ebv
caus
agent
burkitt
lymphoma
interest
histor
note
involv
werner
gertrud
henl
children
hospit
philadelphia
creat
antibodi
ebv
infect
cell
survey
blood
sampl
american
adult
reveal
ebv
posit
also
show
normal
human
lymphocyt
could
made
immort
infect
ebv
know
ebv
silent
infect
children
western
world
infect
bit
later
life
becom
suscept
infecti
mononucleosi
kiss
diseas
adolesc
collabor
georg
klein
manolov
led
discoveri
chromosom
chang
specif
burkitt
lymphoma
chromosom
chang
transloc
rare
zech
et
al
break
point
chromosom
contain
immunoglobin
gene
becom
activ
b
lymphocyt
produc
antibodi
infect
nobel
prize
michael
bishop
harold
varmu
provid
signific
break
point
chromosom
bring
activ
immunoglobin
gene
near
oncogen
cmyc
second
cancer
common
north
east
africa
well
southern
china
found
ebv
posit
carcinoma
postnas
space
nasal
pharyng
carcinoma
npc
tumor
observ
epitheli
cell
bcell
geograph
link
endem
malaria
region
case
appear
aerosol
exposur
environment
carcinogen
possibl
preserv
fish
may
introduc
mutat
nasal
epitheli
cell
npc
may
result
silent
ebv
infect
carcinogen
induc
cellular
mutat
peopl
carri
hla
b
antigen
sever
report
describ
fatal
infecti
mononucleosi
appear
david
purtilo
describ
xlink
prolif
syndrom
xlp
base
intern
registri
boy
fatal
ebv
infect
purtilo
et
al
use
genet
marker
analysi
intern
registri
narrow
xlp
three
million
base
pair
segment
xchromosom
pair
segment
encod
xlp
protein
amino
acid
found
lost
damag
al
xlp
patient
nichol
et
al
curious
xlp
protein
loss
lead
defect
nk
lymphocyt
necessari
recognit
ebv
infect
b
lymphocyt
individu
make
antibodi
ebv
b
cell
requir
help
lymphocyt
develop
potent
immun
suppress
drug
like
cyclosporin
link
lymphoma
organ
transplant
two
girl
acut
lymphoblast
leukemia
receiv
bone
marrow
transplant
hlamatch
brother
graft
success
develop
lymphoblast
leukemia
transplant
male
cell
lymphoma
present
chromosom
transloc
like
burkitt
lymphoma
reveal
new
path
ebv
lymphoma
immun
suppress
upset
ebv
host
homeostasi
crippl
tcell
requir
keep
ebv
control
anoth
situat
viru
replic
without
control
hivaid
patient
aidslymphoma
yet
anoth
ebv
induc
casualti
ebv
provid
key
insight
tumor
associ
viral
infect
first
viru
link
multipl
tumor
differ
popul
includ
burkitt
lymphoma
hodgkin
lymphoma
nasopharyng
carcinoma
second
tumorigenesi
involv
one
mechanist
pathway
interest
focus
latent
membran
ebv
nuclear
antigen
read
gene
third
dissect
associ
infect
ebv
cancer
unfold
period
year
led
greater
understand
cancer
immun
system
method
immort
cell
studi
specif
cell
clonal
popul
ebv
boon
scientif
research
impos
challeng
human
surviv
approxim
billion
peopl
infect
hbv
million
suffer
chronic
infect
acut
hbv
infect
usual
selflimit
associ
million
case
year
chronic
hbv
infect
lead
complic
percent
case
result
million
death
year
hb
v
caus
percent
world
hcc
case
repres
percent
cancer
world
hbx
gene
consid
key
oncogenesi
vaccin
program
effect
reduc
mortal
infant
reduc
emerg
preval
diseas
dietari
exposur
aflatoxin
enhanc
hbvrelat
hcc
sun
et
al
well
coinfect
hcv
excess
alcohol
consumpt
hepat
b
viru
hbv
name
due
differ
transmiss
hepat
type
viru
follow
fecalor
transmiss
b
type
viru
parenter
genom
circular
dna
fulli
doublestrand
end
fulllength
strand
link
dna
polymeras
genom
nucleotid
long
full
length
strand
nucleotid
short
strand
four
gene
encod
includ
c
core
protein
hbcag
synthes
uorf
aug
make
precor
protein
p
dna
polymeras
surfac
antigen
hbsag
three
aug
start
site
divid
gene
x
gene
fulli
understood
may
transcript
transactiv
noncod
rna
includ
hbv
prealpha
hbv
prebeta
hbv
rna
encapsid
signal
epsilon
known
genotyp
differ
percent
sequenc
distinct
geograph
distribut
label
j
least
subtyp
type
f
diverg
form
found
central
south
america
predominantli
brazil
human
hbv
narrow
host
rang
infect
human
higher
primat
eg
chimpanze
woodchuck
hepat
viru
whv
discov
infect
rodent
ground
squirrel
form
identifi
gshv
distant
rel
marmot
woodchuck
inde
dhbv
infect
duck
speci
duck
grey
heron
infect
hhbv
ross
goos
rghbv
snow
goos
sghbv
white
stork
sthbv
crane
chbv
hepadnavirus
arthropod
insect
singlestrand
rna
retroviru
defin
use
revers
transcriptas
polymeras
make
dna
copi
rna
kb
viral
genom
dna
viral
genom
integr
host
genom
refer
proviru
replic
along
host
genom
cell
divis
percent
infect
individu
develop
leukemia
observ
year
asymptomat
infect
tax
protein
like
initi
cell
transform
interact
transcript
activ
cell
cycl
regul
hcv
infect
approxim
percent
world
popul
million
screen
blood
suppli
reduc
preval
hcv
flaviviru
compos
kb
singlestrand
positivesens
rna
hcv
character
singl
serotyp
least
major
genotyp
genotyp
common
genotyp
seen
unit
state
taiwan
hcv
becom
chronic
infect
evad
host
immun
defens
combin
high
replic
rate
virionsday
lack
error
proofread
viral
polymeras
lead
mutat
respons
immun
pressur
genet
variabl
hcv
limit
effort
design
effect
vaccin
polyomavirus
small
kbp
doublestrand
dna
virus
earli
studi
simian
viru
led
identif
larg
tumor
antigen
larg
lt
lt
also
found
bk
jc
virus
suspect
human
tumor
virus
merkel
cell
polyomaviru
mcv
well
establish
human
tumor
viru
feng
et
al
nterminu
lt
contain
lxcxe
motif
interact
retinoblastoma
protein
rb
cterminu
contain
atpasedna
helicas
domain
inactiv
complex
activ
insulinlik
growth
factor
igfi
alon
capabl
cell
transform
picornaviru
famili
small
pico
singlestrand
posit
sens
rna
genom
kb
virus
synthes
singl
polyprotein
cut
small
collect
function
protein
viral
encod
cellular
proteas
polioviru
picornaviru
serv
prototyp
viral
famili
enterovirus
group
picornavirus
associ
cardiac
diseas
coxsackieviru
b
cvb
coxackieviru
cva
echoviru
infect
lead
cardiac
sign
time
onethird
patient
acut
cardiac
diseas
inflamm
heart
antibodi
posit
enterovirus
acut
myocard
often
selflimit
chronic
cardiac
diseas
often
lead
dilat
cardiomyopathi
dcm
present
heart
inflamm
dcm
associ
heart
failur
lethal
tabl
chronic
infect
lead
percent
cardiac
transplant
worldwid
enterovir
proteas
also
degrad
dystrophin
heart
lead
cardiac
necrosi
reduc
eject
fraction
dilat
cardiomyopathi
transmiss
virus
contamin
food
water
human
herpesvirus
larg
doublestrand
dna
genom
virus
human
cytomegaloviru
cmv
kbp
genom
encod
two
hundr
gene
one
problem
find
associ
cmv
infect
emerg
diseas
popul
infect
make
comparison
control
group
challeng
infect
observ
children
newborn
seriou
clinic
find
observ
henc
adult
carri
latent
infect
reactiv
individu
becom
immun
suppress
follow
solid
organ
transplant
malign
hematolog
diseas
aid
reactiv
immun
suppress
individu
associ
increas
mortal
associ
cardiovascular
diseas
demonstr
two
recent
studi
one
cmv
infect
detect
percent
coronari
arteri
sampl
bypass
oper
compar
percent
patient
need
cardiac
surgeri
reason
atherosclerosi
hebar
et
al
cmv
reactiv
viremia
detect
immunocompet
patient
admit
major
heart
surgeri
roa
et
al
incid
coronari
arteri
diseas
major
contributor
death
heart
diseas
diseas
associ
cmv
infect
infect
signific
human
health
hazard
recogn
emerg
infecti
diseas
involv
well
establish
strategi
surveil
identifi
unusu
cluster
diseas
evalu
spread
outbreak
estim
magnitud
problem
possibl
identifi
infecti
agent
strategi
proven
valuabl
known
infecti
noninfecti
diseas
limit
capac
detect
emerg
infecti
diseas
howev
deviat
tradit
approach
surveil
like
gain
support
al
smith
veterinari
virologist
approach
seminar
present
colleg
veterinari
medicin
oregon
state
univers
join
avi
biopharma
head
research
develop
program
al
veterinarian
professor
devot
career
famili
virus
date
back
time
naval
research
station
california
isol
nonhuman
vesiviru
group
calicivirus
suffer
sea
lion
channel
island
reptil
san
diego
zoo
whale
held
captiv
al
capabl
technician
doug
skill
success
propag
viru
isol
cell
cultur
accomplish
share
laboratori
time
al
develop
nucleic
acid
probe
induc
antibodi
viral
isol
decad
research
assembl
extens
collect
vesivirus
held
redund
freezer
singular
vesiviru
focu
gave
appear
zealot
abil
cultiv
viral
isol
extens
collect
isol
one
kind
detect
reagent
made
one
kind
virologist
al
well
beyond
retir
age
old
school
virologist
readi
moment
notic
take
bag
real
world
collect
swab
ail
anim
maintain
care
record
condit
patient
locat
set
anim
commun
everi
field
trip
led
work
lab
propag
viru
swab
al
want
know
would
interest
find
antivir
agent
virus
prime
direct
avi
biopharma
explor
capabl
proprietari
antisens
technolog
yet
investig
target
viru
calicivirus
posit
sens
singlestrand
rna
genom
express
three
gene
singl
polyprotein
identifi
activ
agent
follow
investig
small
collect
candid
stein
et
al
vesiviru
group
calicivirus
consid
anim
believ
infect
human
al
began
explor
human
sampl
collect
detect
reagent
sever
year
make
increment
progress
found
associ
human
blood
sampl
seroposit
vesiviru
marker
liver
diseas
smith
et
al
felt
evid
emerg
infecti
diseas
human
potenti
caus
liver
diseas
would
welcom
medic
commun
al
made
trip
washington
dc
expens
relat
find
person
meet
virologist
nation
institut
health
met
judici
skeptic
harvey
alter
instrument
discoveri
hepat
c
viru
hcv
felt
viral
liver
diseas
alreadi
account
hepat
virus
henc
interest
find
met
american
red
cross
blood
bank
group
shadi
grove
maryland
met
concern
blood
suppli
scrutin
nucleic
acid
test
nat
elimin
viral
contamin
elimin
blood
sampl
would
threaten
alreadi
limit
inventori
find
simpli
add
complic
blood
suppli
busi
ask
compel
extens
data
add
robust
claim
problem
interest
provid
financi
support
recommend
studi
conundrum
common
need
data
convinc
grant
agenc
support
work
support
add
limit
data
life
cut
edg
frequent
discourag
strategi
took
two
path
one
seek
commerci
support
creat
proof
concept
data
antivir
solut
logic
commerci
solut
meet
michael
houghton
chiron
drive
scientif
forc
find
hcv
chiron
might
like
ad
reput
find
anoth
previous
unrecogn
hepat
viru
inde
dr
houghton
invit
us
bay
area
discuss
project
review
data
qualiti
al
detect
reagent
chiron
provid
modest
support
inhous
laboratori
help
confirm
observ
glimmer
hope
al
creat
compani
calicitech
could
accept
support
licens
reagent
patent
univers
test
antivir
agent
human
would
expens
absenc
natur
histori
infect
would
make
human
proof
concept
imposs
howev
al
contact
cat
rescu
facil
atlanta
mommi
cat
describ
outbreak
felin
caliciviru
fecv
catteri
cat
vaccin
approv
fecv
vaccin
fail
protect
cat
veterinarian
decid
use
altern
medicin
altern
owner
oc
cat
sign
equival
inform
consent
provid
fecv
specif
antivir
mommi
cat
along
detail
protocol
treatment
infect
kitten
treat
surviv
treat
die
provid
encourag
data
discov
similar
outbreak
human
societi
facil
eugen
oregon
neighbor
reach
agreement
treat
infect
kitten
success
smith
et
al
first
time
treat
infect
base
symptom
outbread
popul
cat
kitten
patient
remark
surviv
differ
treat
untreat
proof
concept
diseas
cluster
link
human
vesiviru
noroviru
caliciviru
known
infect
human
fact
well
known
cruis
ship
day
care
center
extend
care
retir
facil
effort
human
vesiviru
recogn
emerg
infecti
diseas
fail
chiron
impress
antivir
longer
interest
evalu
detect
reagent
lucki
human
vesiviru
infect
remain
mild
clinic
odditi
al
smith
interest
way
respond
viru
infect
human
go
away
singl
strand
dna
viru
infect
human
known
caus
diseas
lack
patholog
led
use
viral
vector
human
gene
therapi
aav
infect
divid
quiescent
cell
persist
extra
chromosom
without
integr
genom
host
cell
aav
member
parvovirida
famili
genu
dependoparvoviru
arenaviru
close
relat
lassa
viru
share
reservoir
host
mv
natur
attenu
nonpathogen
human
infect
human
mv
protect
lethal
challeng
lv
wulff
et
al
flaviviru
pegiviru
flavivirida
name
g
barker
surgeon
first
identifi
hgv
infect
one
sixth
world
popul
caus
human
diseas
metaanalysi
public
investig
gbvc
infect
hivposit
individu
indic
coinfect
gbvc
slow
progress
hiv
diseas
individu
seroposit
year
zhang
et
al
two
studi
investig
gbvc
year
document
hiv
seroconvers
estim
hazard
ratio
ci
retroviru
first
identifi
lymphoblastoid
cell
cultur
kenyan
patient
nasopharyng
carcinoma
hfv
homolog
primat
foami
virus
close
relat
chimpanze
foami
viru
sfvcpz
earli
studi
rais
alarm
associ
autoimmun
diseas
extens
studi
precis
diagnost
reagent
fail
find
diseas
associ
hfv
hfv
rare
human
infect
concern
parallel
sfv
infect
human
retroviru
infect
primat
born
captiv
peopl
make
contact
infect
primat
becom
infect
human
infect
frequent
occur
male
probabl
requir
bite
infect
nonhuman
primat
harmless
infect
cell
often
fuse
form
syncytia
giant
foami
cell
give
viru
name
error
rate
sfv
genom
except
low
x
substitut
per
site
per
year
compar
hiv
substitut
per
site
per
year
sinc
socal
crossspeci
infect
observ
littl
decad
long
term
consequ
known
infect
watch
wait
everyth
zoonot
epidem
identifi
diseas
cluster
perhap
exactli
sort
infect
emerg
signific
human
concern
futur
singlestrand
posit
sens
dna
genom
viru
kb
size
famili
nearli
percent
even
healthi
individu
infect
countri
viru
discov
transfus
transmit
viru
ttv
japanes
patient
often
found
patient
liver
diseas
caus
hepat
close
relat
torqu
teno
mini
viru
ttmv
isol
found
smaller
genom
kb
ttmv
infect
also
common
caus
describ
human
diseas
use
creat
ebolaviru
ebov
vaccin
encod
zair
ebolaviru
glycoprotein
fail
protect
anim
immun
replic
defect
chimpanzeederiv
adenoviru
provid
protect
lethal
ebov
challeng
macaqu
protect
wane
sever
month
boost
modifi
vaccinia
ankara
mvabnfilo
led
durabl
protect
stanley
et
al
vaccin
progress
phase
singleblind
random
human
trial
mali
singl
dose
effici
prime
vaccin
strategi
follow
mvabnfilo
boost
well
toler
human
tapia
et
al
base
doublestrand
dna
viru
infect
less
percent
human
popul
wu
name
washington
univers
found
coinfect
variou
respiratori
infect
wu
caus
diseas
wu
close
relat
ki
viru
also
known
caus
clinic
diseas
howev
relat
polyomavirus
clinic
relev
includ
bk
viru
associ
nephropathi
jc
viru
associ
progress
multifoc
leukoencephalopathi
viru
associ
mesothelioma
merkel
cell
polyomaviru
associ
cancer
vaccinia
viru
orthopoxviru
larg
doubl
strand
dna
viru
close
relat
smallpox
edward
jenner
father
immunolog
found
milkmaid
expos
cowpox
vaccinia
immun
smallpox
first
vaccin
name
vaccinia
lead
modern
vaccin
allow
erad
smallpox
viral
sequenc
constantli
mutat
purpos
seek
survivalinfect
benefit
mean
virus
current
patholog
repres
premut
reservoir
next
catastroph
human
pandem
popular
rnaseq
like
expand
catalog
nonpathogen
viral
infect
howev
manag
inform
question
technolog
use
counter
viral
infect
result
approv
drug
treatment
nine
differ
human
viral
infect
year
de
clercq
li
sever
differ
antivir
drug
group
report
follow
aris
review
mechan
action
antivir
drug
assembl
tabl
inhibit
viral
attach
entri
inhibit
viral
uncoat
viral
polymeras
inhibitor
nucleotid
analogu
ntrti
nonnucleotid
revers
transcriptas
inhibitor
nnrti
dna
polymeras
inhibitor
nucleic
acid
synthesi
inhibitor
nucleotid
pool
size
agent
latenc
revers
agent
integras
inhibitor
proteas
inhibitor
hiv
hcv
neuraminidas
inhibitor
immun
respons
modifi
antisens
inhibitor
administr
hyperimmun
sera
immun
anim
human
donor
first
effect
treatment
infecti
diseas
practic
limit
still
use
treat
bacteri
toxin
viral
infect
caus
cmv
rsv
hav
hbv
rabv
vzv
mev
keller
stiehm
develop
human
human
monoclon
antibodi
humab
creat
feasibl
way
rapidli
gener
novel
antivir
therapeut
humab
advantag
serum
therapi
chemic
defin
reagent
minim
variabl
greater
activ
per
mass
protein
immunolog
consequ
relat
serum
sick
sever
mab
approv
treatment
infecti
diseas
includ
viral
bacteri
pathogen
tabl
antivir
mab
discoveri
field
explod
activ
particularli
hiv
hcv
infect
human
mab
target
lymphocyt
receptor
call
demonstr
potent
prolong
activ
larg
margin
safeti
jacobson
et
al
administr
pro
subcutan
rout
offer
patient
way
selfadminist
mab
importantli
mab
transport
lymphat
provid
enhanc
access
bind
cellular
target
jacobson
et
al
next
gener
antivir
therapeut
like
domin
mab
perhap
way
clear
viral
infect
involv
host
immun
respons
tabl
innat
immun
respons
particularli
effect
center
type
pathway
unfortun
mani
virus
carri
mechan
evad
host
innat
respons
innat
immun
effector
capac
memori
adapt
immun
respons
mitig
infect
antibodi
gener
surfac
antigen
prevent
spread
viru
tlymphocyt
clear
virusinfect
cell
rnabas
therapeut
offer
ration
design
expans
number
new
antivir
strategi
advantag
superimpos
theoret
advantag
select
specif
affin
provid
watsoncrick
base
pair
rnabas
therapeut
expect
provid
substanti
narrow
rang
pharmacokinet
properti
toxic
thu
easier
compar
ultim
combin
multiag
cocktail
howev
mechan
action
may
vari
rnase
h
risc
mediat
degrad
target
rna
steric
inhibit
rna
function
object
antivir
program
exploit
broad
understand
rnabas
therapeut
antivir
activ
common
chemic
type
phosphorodiamid
morpholino
oliogm
pmo
enhanc
deriv
way
mechan
action
common
agent
steric
blockad
rna
function
studi
report
zamecnik
stevenson
introduc
first
approach
identif
antisens
antivir
agent
zamecnik
stephenson
stephenson
zamecnik
use
target
rou
sarcoma
viru
sinc
rou
sarcoma
viru
pioneer
effort
antivir
rna
base
therapeut
involv
multipl
oligom
chemistri
varieti
differ
mechan
action
chemic
approach
oligom
direct
hiv
plenti
nonion
methylphosphon
oligonucleotid
target
splice
acceptor
site
hiv
tat
inhibit
splice
viral
rna
sarin
et
al
inhibit
syncytia
format
synthesi
concentr
poor
aqueou
solubl
limit
util
methylphosphon
chemistri
phosphoramid
chemistri
investig
inhibit
splicedonor
spliceacceptor
hiv
tat
agraw
et
al
potent
agent
cytotox
poorli
water
solubl
phosphorothio
chemistri
target
hivrev
matsukura
et
al
hivtat
shown
effect
inhibit
hiv
replic
cytotox
solubl
hivrev
phosphorothio
oligodeoxynucleotid
stabl
vivo
accept
pharmacokinet
profil
iversen
et
al
phoshorothio
call
target
initi
site
hivgag
evalu
clinic
trial
agraw
trial
discontinu
focus
phosphorodiamid
morpholino
oligom
chemistri
stabl
netneutr
charg
physiolog
ph
virus
simpl
term
genom
size
number
potenti
translat
viral
protein
genom
linear
enter
cell
readi
translat
design
steric
block
rnabas
therapeut
involv
prevent
translat
disrupt
rna
secondari
structur
mask
recognit
site
rna
depend
rna
polymeras
rdrp
target
either
first
orfaug
activ
efficaci
anim
challeng
studi
observ
high
fidel
effect
agent
identifi
vitro
employ
famili
six
differ
human
astrovirus
huastv
respons
gastroenter
found
effect
site
target
also
optim
site
calicivirida
includ
vesiviru
vev
martinalonso
et
al
stein
et
al
noroviru
nov
bok
et
al
felin
caliciviru
fcv
smith
et
al
flavivirida
includ
dengu
den
kinney
et
al
holden
et
al
west
nile
viru
wnv
dea
et
al
zhang
et
al
arterivirida
includ
agricultur
import
equin
arteriviru
eav
van
den
born
et
al
porcin
respiratori
reproduct
viru
prrsv
zhang
et
al
b
togavirida
exemplifi
venezuelan
equin
enceph
viru
veev
paessler
et
al
famili
coronavirida
reveal
new
activ
target
site
transcript
regulatori
sequenc
mous
hepat
viru
mhv
neuman
et
al
sever
acut
respiratori
syndrom
viru
sar
neuman
et
al
activ
target
site
involv
highli
conserv
sequenc
intern
ribosom
entri
site
ire
polio
viru
pv
stone
et
al
foot
mouth
diseas
viru
fmdv
vagnozzi
et
al
coxsackieviru
yuan
et
al
virus
gener
complex
respect
genom
size
number
potenti
translat
viral
protein
multipl
genom
segment
genom
must
replic
prior
translat
viral
protein
design
steric
block
rnabas
therapeut
similar
posit
sens
rna
genom
target
involv
prevent
translat
mask
recognit
site
rna
depend
rna
polymeras
rdrp
investig
differ
target
measl
viru
mev
member
find
translat
initi
start
site
n
optim
target
sleeman
et
al
studi
human
respiratori
syncyti
viru
hrsv
found
translat
site
l
activ
lai
et
al
studi
investig
influenza
viru
probe
viral
segment
find
translat
activ
well
termin
vnp
ge
et
al
lupfer
et
al
combin
target
requir
anim
studi
high
pathogen
viral
isol
gabriel
et
al
extens
influenza
studi
reveal
new
target
msegment
splice
donor
site
target
evalu
phase
clinic
trial
antisens
platform
technolog
limit
target
viral
sequenc
inhibit
viral
encod
protein
block
viral
replic
interf
polymeras
alway
work
arenavirida
famili
prove
difficult
experienc
success
junin
lymphochoriomening
viru
lcmv
cell
cultur
observ
reduct
viral
titer
pmo
target
highli
conserv
viral
genom
terminu
howev
fail
provid
surviv
benefit
guinea
pig
challeng
either
junin
lassa
viru
tri
mous
challeng
lcmv
fail
observ
hemorrhag
diseas
mous
sever
consequ
infect
mimic
worst
aspect
arenavir
infect
decid
tri
target
host
gene
mitig
diseas
mous
found
target
provid
surviv
benefit
schnell
et
al
success
face
failur
put
target
host
gene
center
attent
deal
emerg
infecti
diseas
antisens
platform
technolog
repres
excel
approach
rapid
drug
discoveri
emerg
infecti
diseas
rapid
discoveri
demonstr
repeatedli
cours
cost
advanc
develop
daunt
applic
best
immedi
treatment
index
case
close
contact
healthcar
worker
gorilla
room
everyon
room
consid
someon
els
problem
current
cours
ignor
majest
creatur
start
tear
limb
peopl
consensu
kill
gorilla
agenc
like
world
health
organ
center
diseas
control
cdc
nation
institut
health
nih
assembl
highli
skill
personnel
confer
greatest
mind
world
unfortun
awar
potenti
problem
emerg
pandem
like
take
us
surpris
signific
specul
singlestrand
rna
viru
emerg
kill
ten
million
peopl
cost
hundr
billion
dollar
chang
cours
human
histori
high
probabl
viru
influenza
jump
reservoir
popul
bird
establish
humantohuman
transmiss
pandem
global
event
time
effect
vaccin
avail
neuraminidas
na
inhibitor
therapeut
prophylact
agent
set
pandem
influenza
flua
call
doubt
past
decad
michiel
et
al
jefferson
et
al
inde
isol
pandem
found
resist
adamantan
resist
oseltamivir
tamiflu
osl
observ
viru
recov
individu
take
osl
therapeut
prophylact
dharan
et
al
cdc
mmwr
effect
durat
shed
impact
recent
outbreak
influenza
viru
caus
case
death
china
reveal
novel
na
mutat
result
high
level
resist
osl
wang
et
al
therapeut
option
treatment
individu
complic
influenza
sever
limit
perhap
option
pandem
strain
carri
signific
morbid
mortal
particularli
experienc
influenza
lifetim
also
wit
rapidli
emerg
highli
pathogen
avian
influenza
strain
result
human
infect
appear
becom
effici
persontoperson
transmiss
report
suggest
osl
resist
develop
treatment
de
jong
et
al
lam
et
al
readi
outbreak
avian
flu
emerg
singlestrand
rna
viru
estim
time
cost
develop
new
drug
year
billion
commerci
use
drug
emerg
infect
hard
estim
sinc
definit
start
develop
infect
emerg
us
would
unlik
use
retir
save
invest
drug
develop
project
reliabl
way
expect
return
invest
poor
busi
model
consid
may
hundr
emerg
infecti
diseas
time
year
billion
task
daunt
diseas
focu
consid
ebola
drug
ebola
therapeut
project
began
follow
laboratori
accid
usamriid
identifi
three
compound
activ
combin
observ
unpreced
efficaci
lethal
challeng
primat
anim
model
warfield
et
al
hundr
experi
next
year
optim
agent
swenson
et
al
abl
obtain
research
grant
transform
medic
technolog
tmt
divis
defens
threat
reduct
agenc
dtra
within
depart
defens
dod
complet
proof
efficaci
studi
warren
et
al
led
submiss
investig
new
drug
applic
ind
food
drug
agenc
fda
phase
safeti
toler
studi
conduct
healthi
human
volunt
heald
et
al
year
continu
effort
complet
key
aspect
relat
fda
approv
process
anim
rule
streamlin
treatment
singl
agent
warren
et
al
howev
shortli
ebola
outbreak
western
africa
us
govern
budget
sequest
cancel
project
advanc
therapeut
planet
deploy
treat
infect
outbreak
outbreak
continu
found
viral
resist
unlik
monoclon
antibodi
therapi
use
khiabanian
et
al
sit
shelf
polit
casualti
unfavor
busi
model
global
virospher
may
contain
virusviruslik
particl
suttl
greatest
reservoir
genet
divers
earth
atmospher
transport
virus
planet
virus
found
soil
x
x
particl
per
gram
dri
soil
kimura
et
al
surfac
ocean
carri
approxim
ten
million
viral
particl
millilit
seawat
bacteriophag
phage
small
viral
particl
easili
carri
upper
atmospher
draft
wind
bacteria
deposit
atmospher
rate
x
per
meter
day
viral
deposit
rate
time
greater
rech
et
al
phage
influenc
bacteri
lifecycl
play
role
natur
energi
nutrient
cycl
fundament
life
earth
dynam
phagebacteri
evolut
drive
chang
photosynthesi
phosphat
nitrogen
balanc
breitbart
human
accident
releas
radioact
wast
discuss
chap
dispos
chemic
includ
potent
antivir
antibacteri
compound
discuss
chap
may
alter
ecoevolutionari
dynam
produc
unanticip
environment
consequ
object
chapter
provid
convinc
evid
infecti
diseas
signific
threat
human
health
focu
viral
infect
reli
host
ribosom
produc
protein
recent
emerg
infect
singlestrand
rna
genom
virus
replic
rna
virus
error
prone
pandem
infect
accompani
rise
human
civil
frequent
reoccur
leav
last
imprint
human
histori
punctuat
profound
loss
life
emerg
infect
becom
endem
annual
death
toll
decad
bring
new
onslaught
emerg
infecti
agent
surpris
never
prepar
inevit
catastrophi
longterm
consequ
often
remain
unrecogn
alway
inconveni
cancer
cardiovascular
diseas
immun
associ
diseas
threaten
health
relianc
cluster
clinic
symptom
face
divers
nondescript
viral
infect
symptom
foolhardi
form
crisi
manag
infecti
diseas
certainli
continu
pose
signific
threat
human
health
age
cell
phone
artifici
intellig
global
commerc
rapid
replic
viral
genom
combin
low
fidel
polymeras
provid
foundat
unend
sourc
new
emerg
infecti
agent
trait
also
make
viral
genom
sensit
environment
contamin
way
may
expand
probabl
zoonosi
infecti
diseas
part
environ
appreci
studi
infecti
diseas
part
curricula
student
environment
sciencemanag
textbook
environment
studi
includ
chapter
infecti
diseas
integr
research
superfund
site
focus
chemic
contamin
infect
zoonosi
would
result
valuabl
insight
threat
analysi
virus
rna
genom
lack
sequenc
proofread
qualiti
control
replic
cumul
mutat
genom
limit
genom
size
base
essenti
larger
genom
would
evolv
exist
call
catastroph
evolut
limit
genom
size
make
virus
except
resili
chang
environ
viru
must
econom
combin
function
mean
evolut
resili
thing
rna
genom
virus
uniqu
insight
human
evolut
restrict
dna
genom
resili
limit
rna
rna
genom
virus
